Jagsonpal Pharmaceuticals Limited has informed the Exchange about Resignation of Director/KMP/SMP
JAGSNPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Mrs. Pallavi Dinodia Gupta has resigned as an Independent Director of Jagsonpal Pharmaceuticals Limited effective May 18, 2026. She cited personal reasons including increasing professional commitments, personal engagements, health considerations, and the need to balance her existing responsibilities. She confirmed there are no other material reasons for her resignation beyond those stated. With her departure, she also ceases to be a member of the Audit Committee, Corporate Social Responsibility Committee, and Chairperson of the Stakeholders Relationship Committee. Mrs. Gupta remains an Independent Director on the boards of IndiaMART InterMESH Limited, Voith Paper Fabrics India Limited, and Lumax Industries Limited.
This resignation reduces the board's independent oversight capacity and creates a vacancy in key committee positions. The company will need to appoint a new Independent Director to maintain compliance with SEBI regulations. While the stated personal reasons and explicit no-material-reason confirmation are reassuring, the departure of an independent director can raise minor governance concerns for investors in the short term.